Related Experiment Video
Updated: Jul 9, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter pylori infection and pregnancy-related issues: literature review
E Lam1, K Kotilea2, P Bontems2
1Department of Gastroenterology, Hepatology and Digestive Oncology. Hôpitaux Universitaires de Bruxelles (HUB), Brussels, Belgium.
Abstract:
Helicobacter pylori (H. pylori) is a gram-negative bacterium that infects approximately half of the worldwide population. Although asymptomatic in most people, it can cause non-ulcer dyspepsia, gastro-duodenal ulcer disease and gastric cancer. H. pylori infection has also been correlated with extra-intestinal diseases like unexplained iron-deficiency anemia, immune thrombocytopenia and vitamin B12 deficiency. Its impact on pregnancy issues has also been studied, but the relationship is less clear. Recently, multiple meta-analyses found that H. pylori infection is correlated with gestational diabetes mellitus, preeclampsia, nausea and hyperemesis gravidarum, and adverse birth outcomes such as birth defects and fetal growth restriction. There is no recommendation for treating H. pylori infection during pregnancy according to the Maastricht VI consensus. This article aims to state the current knowledge about H. pylori infection and pregnancy-related diseases.
Related Concept Videos
Peptic Ulcer
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
